Results 141 to 150 of about 2,541 (192)
Cost-effectiveness of end-game strategies against sleeping sickness across the Democratic Republic of Congo. [PDF]
PLoS Negl Trop DisAntillon M +16 more
europepmc +1 more source
Changes in the diagnosis and management of polycystic ovary syndrome in adolescents based on recommendations of scientific societies over the last decade. [PDF]
Pediatr Endocrinol Diabetes MetabKamińska G, Chmiela S, Kucharska A.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
American Journal of Clinical Dermatology, 2001
Eflornithine is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase which is thought to slow hair growth by inhibiting this enzyme in hair follicles. Percutaneous absorption of eflornithine in women with unwanted facial hair (hirsutism) was < 1% when the 15% cream was applied twice daily to a shaved 50 cm2 area of skin under the ...
exaly +4 more sources
Eflornithine is a specific, irreversible inhibitor of the enzyme ornithine decarboxylase which is thought to slow hair growth by inhibiting this enzyme in hair follicles. Percutaneous absorption of eflornithine in women with unwanted facial hair (hirsutism) was < 1% when the 15% cream was applied twice daily to a shaved 50 cm2 area of skin under the ...
exaly +4 more sources
Pharmaceutisch Weekblad, 1989
Eflornithine (alpha-difluoromethylornithine; DFMO) is a recently developed drug against African trypanosomiasis (sleeping sickness). After a short description of trypanosomiasis and the current treatment, the mechanism of action of eflornithine is discussed, some clinical data is given and attention is paid to recently discovered analogues of ...
A Haemers
exaly +3 more sources
Eflornithine (alpha-difluoromethylornithine; DFMO) is a recently developed drug against African trypanosomiasis (sleeping sickness). After a short description of trypanosomiasis and the current treatment, the mechanism of action of eflornithine is discussed, some clinical data is given and attention is paid to recently discovered analogues of ...
A Haemers
exaly +3 more sources
Eflornithine Plus Sulindac for Prevention of Progression in Familial Adenomatous Polyposis
New England Journal of Medicine, 2020 BACKGROUND: The efficacy and safety of combination therapy with eflornithine and sulindac, as compared with either drug alone, in delaying disease progression in patients with familial adenomatous polyposis are unknown. METHODS: We evaluated the efficacy
Steven Gallinger +2 more
exaly +3 more sources
Journal of the Dermatology Nurses' Association, 2021
ABSTRACT Drugs are substances that exert effects in the body in order to alter an existing physiological or biochemical process. There are several methods of administering drugs, including the use of creams, ointments, liquids, skin patches, capsules, and injections.
Ana Carolina Chen, Janiene D. Luke
openaire +1 more source
ABSTRACT Drugs are substances that exert effects in the body in order to alter an existing physiological or biochemical process. There are several methods of administering drugs, including the use of creams, ointments, liquids, skin patches, capsules, and injections.
Ana Carolina Chen, Janiene D. Luke
openaire +1 more source
Journal of Pharmacokinetics and Pharmacodynamics, 2013 Enantioselective pharmacokinetics and absorption of eflornithine in the rat was investigated using population pharmacokinetic modeling and a modified deconvolution method.
Michael Ashton +2 more
exaly +2 more sources